The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.
A 24-month study in Kenya, Uganda and South Africa has found that injectable HIV treatment, Cabotegravir/Rilpivirine, also known in medical terms as CAB LA + RPV LA, administered every two months, is safe, well-tolerated, and preferred by most HIV patients.
Results from the first 12 months offer renewed hope for adherence to HIV antiretroviral management, reduced HIV related deaths, and enhanced overall quality of life for people living with HIV.
Facts First
This story continues on The Standard INSiDER. Subscribe now for unfiltered journalism that holds power to account.
Already have an account? Login
join